| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 01/15/1998 | WO1998001555A2 Truncated soluble tumor necrosis factor type-i and type-ii receptors |
| 01/15/1998 | WO1998001554A2 Secreted proteins and polynucleotides encoding them |
| 01/15/1998 | WO1998001552A2 Secreted proteins and polynucleotides encoding them |
| 01/15/1998 | WO1998001445A1 Indole derivatives for the treatment of osteoporosis |
| 01/15/1998 | WO1998001436A1 Heteroaromatic pentadienoic acid derivatives useful as inhibitors of bone resorption |
| 01/15/1998 | WO1998001423A1 5-indolyl-2,4-pentadienoic acid derivatives useful as inhibitors of bone resorption |
| 01/15/1998 | WO1998001128A1 Use of l-acetylcarnitine, l-isovalerylcarnitine, l-propionylcarnitine for increasing the levels of igf-1 |
| 01/15/1998 | WO1998001115A1 Combined pharmaceutical estrogen-androgen-progestin oral contraceptive |
| 01/15/1998 | CA2259957A1 Secreted proteins and polynucleotides encoding them |
| 01/15/1998 | CA2259955A1 Secreted proteins and polynucleotides encoding them |
| 01/15/1998 | CA2258525A1 Combined pharmaceutical estrogen-androgen-progestin oral contraceptive |
| 01/14/1998 | EP0708648A4 Inhibition of tumor necrosis factor and nitric oxide production by retinoic acid |
| 01/14/1998 | EP0651738B1 Natural amino acid derivatives as metalloproteinase inhibitors |
| 01/14/1998 | CN1170366A Combined use of diclofenac and tribenoside to treat osteoarthritis |
| 01/14/1998 | CN1170361A Therapeutic perparation for inhalation containing parathyroid hormone, PTH |
| 01/14/1998 | CN1169856A Dual alcohol injection |
| 01/13/1998 | US5707980 Administering 1a,25-dihydroxyvitamin d4 to patient |
| 01/13/1998 | US5707970 Treatment of atheriosclerosis and as nutrients formed by reaction of arginine, silicate salt and inositol |
| 01/08/1998 | WO1998000156A1 Synthetic phosphopeptides for treating bone diseases |
| 01/08/1998 | WO1997041824A3 Antiangiogenic peptides derived from plasminogen |
| 01/08/1998 | WO1997033995A3 Extracellular matrix signalling molecules |
| 01/08/1998 | DE19624154A1 Ringannelierte Dihydropyrane, Verfahren zur Herstellung sowie deren Verwendung Ring Anne lined dihydropyrans, methods of preparation and their use |
| 01/07/1998 | EP0816502A2 Mur A-1, an UDP-N-acetylglucosamine enolpyruvyl-transferase from Streptococcus pneumoniae |
| 01/07/1998 | EP0816497A2 Human requiem polypeptide for apoptosis |
| 01/07/1998 | EP0816380A1 Novel protein and methods for the production of the same |
| 01/07/1998 | EP0815237A1 Threonyl-trna synthetase of staphylococcus aureus |
| 01/07/1998 | EP0815126A1 Bicyclic tachykinins antagonists, preparation thereof and their use in pharmaceutical composition |
| 01/07/1998 | EP0814823A1 Polyphenol fractions of tea, the use thereof and formulations containing them |
| 01/07/1998 | EP0814811A1 Once-a-month-injectable useful as depot contraceptive and in hormone replacement therapy for perimenopausal and premenopausal women |
| 01/07/1998 | CN1169293A Quick-acting resetting and setting fracture powder |
| 01/07/1998 | CN1036920C Heterocycle-containing carbonic acid derivatives |
| 01/06/1998 | US5705507 Aplha-substituted-3-benzyl-benzofurans |
| 01/06/1998 | US5705494 Anti-estrogenic activity of IIβ-substituted-19-NOR Steroids |
| 01/06/1998 | US5705177 Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers |
| 01/06/1998 | US5705167 Treatment of dermatological, rheumatic, respiratory, cardiovascular, bone and ophthalmological disorders |
| 12/31/1997 | WO1997049818A2 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 12/31/1997 | WO1997049702A1 Substituted indazole derivatives and their use as phosphodiesterase (pde) type iv and tumor necrosis factor (tnf) inhibitors |
| 12/31/1997 | WO1997049680A1 Il-8 receptor antagonists |
| 12/31/1997 | WO1997049412A1 Autocross-linked hyaluronic acid and related pharmaceutical compositions for the treatment of arthropathies |
| 12/31/1997 | WO1997049406A1 Use of k-252a derivative for the treatment of peripheral or central nerve disorders, and cytokine overproduction |
| 12/31/1997 | WO1997049286A1 Il-8 receptor antagonists |
| 12/31/1997 | CN1036836C Method for preparing medicine for transcortical application contg. steroidhormonen |
| 12/31/1997 | CA2258850A1 Il-8 receptor antagonists |
| 12/30/1997 | US5703118 Use of benzopyran derivatives for the treatment of pathologies associated with the NA+ -independent CI-/HCO3 -exchanger |
| 12/30/1997 | US5703098 Inhibitors of cytokines including tumor necrosis factor |
| 12/30/1997 | US5703074 Osteoporosis |
| 12/30/1997 | US5703043 Bone morphogenetic protein-10 (BMP-10) compositions |
| 12/30/1997 | US5702724 Compressing inclusion compound containing diclofenac or salt and cyclodextrin into tablets |
| 12/29/1997 | EP0814158A2 Human C3a receptor variant; uses in diagnostics and therapeutics |
| 12/29/1997 | EP0813869A1 Use of strontium salts for the treatment of arthritis |
| 12/29/1997 | EP0813529A1 Arginine analogues having nitric oxide synthase inhibitor activity |
| 12/29/1997 | EP0813414A1 Combination of bisphosphonates and growth hormone secretagogues |
| 12/29/1997 | EP0648120B1 Use of phosphonates for the treatment of osteoporosis |
| 12/24/1997 | WO1997048693A1 Isocoumarin derivatives and use thereof in drugs |
| 12/24/1997 | WO1997048691A1 Ring-fused dihydropyranes, process for the preparation and use thereof |
| 12/24/1997 | WO1997048410A1 Cyclosporin-containing soft capsule preparations |
| 12/24/1997 | WO1997040006A3 Phosphate mimics |
| 12/24/1997 | CN1168695A Inhibitor of stem cell proliferation and uses thereof |
| 12/24/1997 | CN1168677A Novel peptides derived from autoantigent for use in immunotherapy of autoimmune diseases |
| 12/24/1997 | CN1168634A Kit for osteoporosis treatment cycle |
| 12/24/1997 | CN1168633A Boronic ester and acid compounds, synthesis and uses |
| 12/24/1997 | CN1168373A Estrogenic agents |
| 12/24/1997 | CN1168372A 1, 2-diphenylpyrrole derivatives, their preparation and their therapeutic uses |
| 12/24/1997 | CN1036779C Aryl naphthenes derivant and its use |
| 12/23/1997 | US5700911 Bone morphogenetic protein -11 (BMP-11) compositions |
| 12/23/1997 | US5700838 Hydroxamic acid derivatives as metalloproteinase inhibitors |
| 12/23/1997 | US5700774 Treatment of bone disorders |
| 12/18/1997 | WO1997047744A2 T-cell selective interleukin-4 agonists |
| 12/18/1997 | WO1997047618A1 Substituted imidazoles having cytokine inhibitory activity |
| 12/18/1997 | WO1997047577A1 Colchicine-skeleton compounds, their use as medicaments and compositions containing them |
| 12/18/1997 | WO1997047333A1 Novel devices for transdermal administering of trimegestone |
| 12/18/1997 | WO1997035982A3 Monocyte chemotactic protein-5 materials and methods |
| 12/18/1997 | WO1997031895A3 Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| 12/18/1997 | CA2257902A1 Novel devices for transdermal administering of trimegestone |
| 12/18/1997 | CA2256459A1 T-cell selective interleukin-4 agonists |
| 12/16/1997 | US5698690 Hydroxamic acid derivatives with tricyclic substitution |
| 12/16/1997 | US5698542 Compound comprising tetracycline type antibiotic linked to steroid type hormone |
| 12/16/1997 | US5698519 Polypeptide specifically inhibiting cathepsin L |
| 12/11/1997 | WO1997046686A2 Tumor necrosis factor-related polypeptide |
| 12/11/1997 | WO1997046671A1 Enhanced efficacy of liposomal antisense delivery |
| 12/11/1997 | WO1997046548A1 Dihydrobenzopyran and related compounds useful as anti-inflammatory agents |
| 12/11/1997 | WO1997046522A1 Novel vitamin d analogues |
| 12/11/1997 | WO1997046252A1 Growth hormone component and bone anti-resorptive agent in cyclic (coherence) treatment of osteoporosis |
| 12/11/1997 | WO1997040017A3 Modulators of molecules with phosphotyrosine recognition units |
| 12/11/1997 | CA2257174A1 Growth hormone component and bone anti-resorptive agent in cyclic (coherence) treatment of osteoporosis |
| 12/11/1997 | CA2256464A1 Tumor necrosis factor-related polypeptide |
| 12/11/1997 | CA2256456A1 Enhanced efficacy of liposomal antisense delivery |
| 12/10/1997 | EP0811383A1 Remedies for arthrosis deformans and inflammatory joint diseases |
| 12/10/1997 | EP0811063A2 Chemokine receptors 88-2b ckr-3] and 88c and their antibodies |
| 12/10/1997 | CN1167437A Method of using triaryl-ethylene derivatives in the treatment and prevention of osteoporosis |
| 12/09/1997 | US5696123 Neurokinin antagonists |
| 12/09/1997 | US5695955 Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis |
| 12/04/1997 | WO1997045447A1 METHODS AND COMPOSITIONS USEFUL FOR INHIBITION OF αvβ5 MEDIATED ANGIOGENESIS |
| 12/04/1997 | WO1997045425A1 New indolyl and benzofuranyl carboxamides as inhibitors of nitric oxide production |
| 12/04/1997 | WO1997045137A1 Methods and compositions useful for inhibition of angiogenesis |
| 12/04/1997 | WO1997037664A3 Use of 7 alpha-substituted steroids to treat neuropsychiatric, immune or endocrine disorders |
| 12/04/1997 | CA2256588A1 Methods and compositions useful for inhibition of .alpha.v.beta.5 mediated angiogenesis |
| 12/03/1997 | EP0809636A1 Substituted isoxazoles for the treatment of inflammation |
| 12/03/1997 | EP0809512A1 Pharmaceutical non inorganic saline solutions for endonasal administration of a calcitonin |
| 12/03/1997 | EP0809503A1 Method of lessening the risk of vertebral fractures |